⚠️ This content is not available in English.

Authors

[:fr]Anselmi G[:],
[:fr]Vaivode K[:],
[:fr]Ramos RN[:],
[:fr]Missolo-Koussou Y[:],
[:fr]Hidalgo S[:],
[:fr]Tosselo J[:],
[:fr]Nuñez N[:],
[:fr]Richer W[:],
[:fr]Vincent-Salomon A[:],
[:fr]Saxena A[:],
[:fr]Wood K[:],
[:fr]Lladser A[:],
[:fr]Piaggio E[:],
[:fr]Helft J[:],

[:fr]

Abstract

Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1c+CD163+ DCs (called DC3s) as immediate precursors of inflammatory CD88CD14+CD1c+CD163+FcεRI+ DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8+ T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8+CD103+CD69+ tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.

[:en]

Abstract

Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1cCD163 DCs (called DC3s) as immediate precursors of inflammatory CD88CD14CD1cCD163FcεRI DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8 T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8CD103CD69 tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.

[:]

Other publications

Authors :
Rautou Pierre-Emmanuel,
Moga Lucile,
Virginia Hernandez-Gea,
Walter Ageno,
Sarwa Darwish Murad,
Juan-Carlos Garcia-Pagan,
Maria Guido,
Valérie McLin,
Dhiraj Tripathi,
Vilgrain Valérie,
European Association for the Study of the Liver,
Find out more
Authors :
Chloé de Broucker,
Paradis Valérie,
Maria Luisa Botero,
Albuquerque Miguel,
Payancé Audrey,
Plessier Aurélie,
Elkrief Laure,
Durand François,
Sophie Hillaire,
Paul-Emile Zafar,
Juan Carlos Garcia Pagan,
Rautou Pierre-Emmanuel,
Find out more
Authors :
Cambier Alexandra,
Da silva Jennifer,
Bex-Coudrat Julie,
Canesi Fanny,
Lison Lachize Neanne,
Aurélie Sannier,
Hélène Mathieu,
Boedec Erwan,
Amandine Badie,
Monteiro Renato,
Find out more
Authors :
Kouki Ahmed,
Riadh Marrouchi,
Abdelaziz Souli,
Salwa Bouabdallah,
Ferjani Wafa,
Dang Pham My-Chan,
Amadou Dicko,
El Benna Jamel,
Mossadok Ben-Attia,
Find out more